Repeated intrathecal injections of the IL‐18 inhibitor IL‐18 BP once daily on days 12, 13, and 14 post‐tumor inoculation attenuated tumor‐induced mechanical allodynia (Figure 7F), thermal hyperalgesia (Figure 7G), and spontaneous pain (Figure 7H). This evidence concerns the gene IL18 and neoplasm.